Investment Team
Scott Albert
Jeff Clark
Rich Brown
Grant Jackson
Chris Kroeger
Jan Bouten
Administrative Team
Lisa Lavallee
Colleen Suite
Sue Simon
Mike Gorman
Venture Partners
Doug Gooding
Richard Holcomb
Thomas McMurray
Greg Bohlen
Entrepreneur-In-Residence
William New
Advisory Boards
Life Science Advisory Board
Engineering Advisory Board
Advisory Boards

Life Science Advisory Board

Dr. Lowry Caudill

  • Co-founder and President of Pharmaceutical Development, Magellan Pharmaceutical Development
  • Adjunct Professor of Chemistry, University of North Carolina at Chapel Hill
  • Research scientist, Baxter-Trevenol
  • Scientist, Glaxo Research Institute
  • Awards E&Y Entrepreneur of the Year 1997 & 1998, Council for Entrepreneurial Development Entrepreneurial Excellence Award, National Fast 500 Award
  • Fields of Expertise: development and validation of analytical methods, elucidation of product chemistry, and evaluation of product stability for tablets, injectables, syrups, ointments, creams, oral suspensions, and solutions.

Dr. Alfred Childers

  • Co-founder and President of Administration, Magellan Pharmaceutical Development
  • Developer and Manager of Inhalation Analysis Department, Glaxo-SmithKline
  • Principal Investigator of Inhalation Products, Upjohn Company
  • Awards E&Y Entrepreneur of the Year 1997 & 1998, Council for Entrepreneurial Development Entrepreneurial Excellence Award, National Fast 500 Award
  • Fields of Expertise: inhalation product development, laboratory instrument validation (IQ, OQ, PQ), and pharmaceutical extractable analysis, building businesses

Dr. John Falletta

  • Professor of Pediatrics, Chief - Division of Hematology-Oncology, Duke University Medical Center
  • Chairman, Institutional Review Board for Human Investigation, Duke University Medical Center
  • Chairman, Transfusion Committee, Duke University Medical Center
  • Fields of Expertise: Pediatric Oncology and Hematology

Dr. Claude T. Moorman


Dr. Cary Robertson

  • Associate Professor, Division of Urology in the Department of Surgery for Duke Medical Center
  • Fields of Expertise: Adrenal, renal, ureteral, bladder, prostate, and urethral surgery, testis neoplasms

Dr. John Ryals

  • Chairman of the Board, Athenix, Corp.
  • Founder, CEO, Paradigm Genetics
  • Vice President Research, Novartis Crop Protection, Inc.
  • Head of Biotechnology and Genomics Center for Novartis, Inc.
  • Vice-President Biotechnology Research and Intellectual Property, Ciba Seeds
  • Fields of Expertise: Agri-bioscience, genetics, biotechnology, developing small businesses into growth enterprises

Dr. Mary Beth Spanarkel


James Woodward

  • President and Chief Executive Officer, Encelle, Inc.
  • President & CEO, Cardiometrics
  • CFO, Advanced Cardiovascular Systems
  • Co-founder, Ventana Medical Systems, Interventional Technologies, and Accordant Health Services
  • Fields of Expertise:  Managing and developing small life-science businesses into growth enterprises

Dr. Jim Wyngaarden

  • Senior Associate Dean, International Affairs, University of Pennsylvania Medical school
  • Foreign Secretary , U.S. National Academy of Sciences and Institute of Medicine
  • Associate Dean, Duke University Medical School
  • Professor of Medicine, Duke University Medical School
  • Director, National Institutes of Health
  • Director, Human Genome Sciences, Inc.
  • Director, Hybridon, Inc.
  • Awards - John Phillips Memorial Award of the American College of Physicians in 1980, and the Kober Medal of the Association of American Physicians in 1991 and is an honorary member of Sociedad Medica de Santiago de Chile.
  • Fields of Expertise: internationally recognized authority on the regulation of purine biosynthesis and the genetics of gout, and a nationally respected advisor on various aspects of the administration of biomedical research